HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Tetsuya Hashimoto Selected Research

Nicorandil (SG 75)

4/2015Improvement of myocardial fatty acid metabolism by oral nicorandil in hemodialysis patients without coronary artery disease.
1/2014Clinical potential of oral nicorandil to improve myocardial fatty acid metabolism after percutaneous coronary intervention in hemodialysis patients.
1/2011Oral nicorandil for prevention of cardiac death in hemodialysis patients without obstructive coronary artery disease: a propensity-matched patient analysis.
8/2009Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.
1/2009Clinical potential of nicorandil to inhibit major cardiac events in hemodialysis patients with suspected myocardial ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Tetsuya Hashimoto Research Topics

Disease

7Death (Near-Death Experience)
09/2015 - 08/2008
6Coronary Artery Disease (Coronary Atherosclerosis)
09/2015 - 08/2004
5Chronic Kidney Failure (Chronic Renal Failure)
07/2006 - 09/2003
3Alzheimer Disease (Alzheimer's Disease)
09/2011 - 01/2010
3Coronary Stenosis (Coronary Artery Stenosis)
01/2008 - 09/2005
3Diabetes Mellitus
07/2006 - 09/2003
2Insulin Resistance
01/2008 - 06/2006
1Hypoalbuminemia
01/2015
1Left Ventricular Dysfunction
01/2015
1Secondary Hyperparathyroidism
09/2012
1Atrial Fibrillation
09/2012
1Parkinson Disease (Parkinson's Disease)
02/2011
1Cardiac Sudden Death (Sudden Cardiac Arrest)
06/2010
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
06/2010
1Myocardial Infarction
01/2009
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2009
1Hyperglycemia
10/2006
1Thrombosis (Thrombus)
11/2003
1Ventricular Remodeling
09/2003

Drug/Important Bio-Agent (IBA)

6iodofiltic acidIBA
09/2015 - 08/2004
5Nicorandil (SG 75)IBA
04/2015 - 01/2009
2pentadecanoic acidIBA
04/2015 - 07/2006
2Amyloid (Amyloid Fibrils)IBA
02/2011 - 01/2010
2Insulin (Novolin)FDA Link
10/2006 - 06/2006
1Carnitine (L-Carnitine)FDA LinkGeneric
01/2015
1Serum AlbuminIBA
09/2012
1NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA
09/2011
1ApomorphineIBA
02/2011
1Dopamine Agonists (Dopamine Agonist)IBA
02/2011
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2010
1Potassium Channels (Potassium Channel)IBA
01/2009
1Adenosine Triphosphate (ATP)IBA
01/2009
1omega-Chloroacetophenone (Mace)IBA
01/2009
1CytokinesIBA
06/2006
1AdiponectinIBA
06/2006
1Interleukin-10 (Interleukin 10)IBA
06/2006
1HDL CholesterolIBA
06/2006
1Triglycerides (Triacylglycerol)IBA
06/2006
1C-Reactive ProteinIBA
09/2005
1Immunoglobulin G (IgG)IBA
09/2005
1Immunoglobulin A (IgA)IBA
09/2005
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
11/2003
1Brain Natriuretic Peptide (Natrecor)FDA Link
09/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2003

Therapy/Procedure

14Renal Dialysis (Hemodialysis)
09/2015 - 09/2003
2Oral Administration
01/2011 - 08/2009
1Parathyroidectomy
09/2012
1Stents
06/2006